Predictive Oncology Inc. — Director's Dealing 2021

Sep 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2021-09-23

Reporting Person: MYERS ROBERT L (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-23	Common Stock, $.01 par value	M	33334	$1.13	Acquired	33411	Direct
2021-09-23	Common Stock, $.01 par value	D	10200	$1.13	Disposed	23211	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-23	Restricted Stock Units	$	M	33334	Disposed		Common Stock (33334)	Direct

Footnotes

F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.

F2: On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments beginning on the first anniversary of the grant date. The first of these installments vests on September 23, 2021. The remainder vests on each of 9/23/2022 and 9/23/2023.

F3: 10,200 shares of common stock forfeited to Company on September 23, 2021 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.